Prostate Cancer
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.
February 26, 2024
Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis.
February 26, 2024
Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applications.
February 26, 2024
A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancer.
February 26, 2024
Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5.
February 26, 2024
A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group.
February 23, 2024
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration.
February 23, 2024
Reversibility of Bicalutamide PSMA PET-Positive Gynecomastia With Androgen Deprivation Therapy.
February 22, 2024
Gold nanoshells for prostate cancer treatment: evidence for deposition in abdominal organs.
February 22, 2024
Stereotactic ablative radiation therapy in metastatic prostate cancer.
February 22, 2024
Qualitative Study on Internet Use and Care Impact for Black Men With Prostate Cancer.
February 22, 2024
Dissemination of circulating tumor cells in breast and prostate cancer: Implications for early detection.
February 22, 2024